0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Colonoscopic Surveillance after Polypectomy: Considerations of Cost Effectiveness

David F. Ransohoff, MD; Christopher A. Lang, MD; and H. Sung Kuo, MD, MPH
[+] Article and Author Information

Grant Support: In part from the Andrew W. Mellon Foundation.

Requests for Reprints: David F. Ransohoff, MD, IE 61 SHM, P.O. Box 3333, New Haven, CT 06510-8025.

Current Author Addresses: Drs. Ransohoff and Kuo: IE 61 SHM, P.O. Box 3333, New Haven, CT 06510-8025.

Dr. Lang: 457 Williams, Denver, CO 80218.


© 1991 American College of PhysiciansAmerican College of Physicians


Ann Intern Med. 1991;114(3):177-182. doi:10.7326/0003-4819-114-3-177
Text Size: A A A

Objective: To assess the cost effectiveness of the current recommendation that persons who have had an adenomatous colon polyp removed have periodic colonoscopic surveillance at fixed and regular intervals.

Design: Cost-effectiveness analysis using data from the medical literature in a simulation model to estimate the costs of and the risk for perforation associated with periodic colonoscopic surveillance for a 50-year-old man followed for 30 years.

Main Results: A program of colonoscopy every 3 years would incur cumulatively a 1.4% risk for colon perforation, a 0.11% risk for perforation-related death, and direct physician costs of $2071 for colonoscopy (discounted at 5%). If a 50-year-old man's cumulative remaining risk for death from cancer is 2.5% after the removal of a single small adenoma and if effectiveness of colonoscopic surveillance every 3 years is 100%, then one death from cancer could be prevented by doing 283 colonoscopies, incurring 0.6 perforations, 0.04 perforation-related deaths, and direct physician costs of $82 000. If surveillance were 50% effective and the cumulative remaining risk for death from cancer were 1.25%—a plausible scenario—1131 colonoscopies would be required to prevent one death from cancer, incurring 2.3 perforations, 0.17 perforation-related deaths, and physician costs of $331 000.

Conclusions: The cost effectiveness of colonoscopic surveillance is very sensitive to estimates of the cumulative remaining risk for death from cancer after polypectomy as well as to surveillance efficacy. For persons whose remaining risk for death from cancer may be low, such as persons with a single small adenoma, recommendations for colonoscopic surveillance at fixed and regular intervals may be excessively costly.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Follow-up after polypectomy: consensus? Eur J Cancer 1995 Jul-Aug;31A(7-8):1141-4.
Hereditary colorectal cancer: screening and management. Curr Treat Options Oncol 2002;3(6):459-74.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)